238 related articles for article (PubMed ID: 16497967)
1. Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas.
Fu L; Lin-Lee YC; Pham LV; Tamayo A; Yoshimura L; Ford RJ
Blood; 2006 Jun; 107(11):4540-8. PubMed ID: 16497967
[TBL] [Abstract][Full Text] [Related]
2. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL.
He B; Chadburn A; Jou E; Schattner EJ; Knowles DM; Cerutti A
J Immunol; 2004 Mar; 172(5):3268-79. PubMed ID: 14978135
[TBL] [Abstract][Full Text] [Related]
3. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome.
Novak AJ; Grote DM; Stenson M; Ziesmer SC; Witzig TE; Habermann TM; Harder B; Ristow KM; Bram RJ; Jelinek DF; Gross JA; Ansell SM
Blood; 2004 Oct; 104(8):2247-53. PubMed ID: 15251985
[TBL] [Abstract][Full Text] [Related]
4. Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival.
Pham LV; Tamayo AT; Yoshimura LC; Lin-Lee YC; Ford RJ
Blood; 2005 Dec; 106(12):3940-7. PubMed ID: 16099873
[TBL] [Abstract][Full Text] [Related]
5. A role of both NF-κB pathways in expression and transcription regulation of BAFF-R gene in multiple myeloma cells.
Shen X; Zhu W; Zhang X; Xu G; Ju S
Mol Cell Biochem; 2011 Nov; 357(1-2):21-30. PubMed ID: 21607696
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI.
Marsters SA; Yan M; Pitti RM; Haas PE; Dixit VM; Ashkenazi A
Curr Biol; 2000 Jun; 10(13):785-8. PubMed ID: 10898980
[TBL] [Abstract][Full Text] [Related]
7. The rGel/BLyS fusion toxin inhibits diffuse large B-cell lymphoma growth in vitro and in vivo.
Lyu MA; Rai D; Ahn KS; Sung B; Cheung LH; Marks JW; Aggarwal BB; Aguiar RC; Gandhi V; Rosenblum MG
Neoplasia; 2010 May; 12(5):366-75. PubMed ID: 20454508
[TBL] [Abstract][Full Text] [Related]
8. NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells.
Hatada EN; Do RK; Orlofsky A; Liou HC; Prystowsky M; MacLennan IC; Caamano J; Chen-Kiang S
J Immunol; 2003 Jul; 171(2):761-8. PubMed ID: 12847243
[TBL] [Abstract][Full Text] [Related]
9. BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-kappaB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells.
Fu L; Lin-Lee YC; Pham LV; Tamayo AT; Yoshimura LC; Ford RJ
Blood; 2009 May; 113(19):4627-36. PubMed ID: 19258594
[TBL] [Abstract][Full Text] [Related]
10. BLyS BINDS TO B CELLS WITH HIGH AFFINITY AND INDUCES ACTIVATION OF THE TRANSCRIPTION FACTORS NF-kappaB AND ELF-1.
Kanakaraj P; Migone TS; Nardelli B; Ullrich S; Li Y; Olsen HS; Salcedo TW; Kaufman T; Cochrane E; Gan Y; Hilbert DM; Giri J
Cytokine; 2001 Jan; 13(1):25-31. PubMed ID: 11145839
[TBL] [Abstract][Full Text] [Related]
11. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.
Kayagaki N; Yan M; Seshasayee D; Wang H; Lee W; French DM; Grewal IS; Cochran AG; Gordon NC; Yin J; Starovasnik MA; Dixit VM
Immunity; 2002 Oct; 17(4):515-24. PubMed ID: 12387744
[TBL] [Abstract][Full Text] [Related]
12. BLyS and BLyS receptor expression in non-Hodgkin's lymphoma.
Briones J; Timmerman JM; Hilbert DM; Levy R
Exp Hematol; 2002 Feb; 30(2):135-41. PubMed ID: 11823048
[TBL] [Abstract][Full Text] [Related]
13. The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA.
Lyu MA; Cheung LH; Hittelman WN; Marks JW; Aguiar RC; Rosenblum MG
Mol Cancer Ther; 2007 Feb; 6(2):460-70. PubMed ID: 17267661
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis.
Pham LV; Tamayo AT; Yoshimura LC; Lo P; Ford RJ
J Immunol; 2003 Jul; 171(1):88-95. PubMed ID: 12816986
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic effects of rGel/BLyS fusion toxin in in vitro and in vivo models of mantle cell lymphoma.
Lyu MA; Pham LV; Sung B; Tamayo AT; Ahn KS; Hittelman WN; Cheung LH; Marks JW; Cho MJ; Ford RJ; Aggarwal BB; Rosenblum MG
Biochem Pharmacol; 2012 Aug; 84(4):451-8. PubMed ID: 22687624
[TBL] [Abstract][Full Text] [Related]
16. Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma.
Zhou HJ; Pham LV; Tamayo AT; Lin-Lee YC; Fu L; Yoshimura LC; Ford RJ
Blood; 2007 Sep; 110(6):2121-7. PubMed ID: 17567982
[TBL] [Abstract][Full Text] [Related]
17. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
18. Immunology. Lymphocyte survival--ignorance is BLys.
Laâbi Y; Strasser A
Science; 2000 Aug; 289(5481):883-4. PubMed ID: 10960320
[TBL] [Abstract][Full Text] [Related]
19. Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1.
Xu LG; Wu M; Hu J; Zhai Z; Shu HB
J Leukoc Biol; 2002 Aug; 72(2):410-6. PubMed ID: 12149433
[TBL] [Abstract][Full Text] [Related]
20. Fusion toxin BLyS-gelonin inhibits growth of malignant human B cell lines in vitro and in vivo.
Luster TA; Mukherjee I; Carrell JA; Cho YH; Gill J; Kelly L; Garcia A; Ward C; Oh L; Ullrich SJ; Migone TS; Humphreys R
PLoS One; 2012; 7(10):e47361. PubMed ID: 23056634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]